Departamento de Química Física, Universidad de Valencia, 46100 Burjassot, Spain.
Instituto de Materiales Avanzados, Universidad Jaume I, 12071 Castelló, Spain.
J Chem Inf Model. 2023 Sep 11;63(17):5676-5688. doi: 10.1021/acs.jcim.3c00900. Epub 2023 Aug 27.
l-asparaginases catalyze the asparagine hydrolysis to aspartate. These enzymes play an important role in the treatment of acute lymphoblastic leukemia because these cells are unable to produce their own asparagine. Due to the immunogenic response and various side effects of enzymes of bacterial origin, many attempts have been made to replace these enzymes with mammalian enzymes such as human asparaginase type III (hASNaseIII). This study investigates the reaction mechanism of hASNaseIII through molecular dynamics simulations, quantum mechanics/molecular mechanics methods, and free energy calculations. Our simulations reveal that the dimeric form of the enzyme plays a vital role in stabilizing the substrate in the active site, despite the active site residues coming from a single protomer. Protomer-protomer interactions are essential to keep the enzyme in an active conformation. Our study of the reaction mechanism indicates that the self-cleavage process that generates an N-terminal residue (Thr168) is required to activate the enzyme. This residue acts as the nucleophile, attacking the electrophilic carbon of the substrate after a proton transfer from its hydroxyl group to the N-terminal amino group. The reaction mechanism proceeds with the formation of an acyl-enzyme complex and its hydrolysis, which turns out to be the rate-determining step. Our proposal of the enzymatic mechanism sheds light on the role of different active site residues and rationalizes the studies on mutations. The insights provided here about hASNaseIII activity could contribute to the comprehension of the disparities among different ASNases and might even guide the design of new variants with improved properties for acute lymphoblastic leukemia treatment.
天冬酰胺酶催化天冬酰胺的水解生成天冬氨酸。这些酶在治疗急性淋巴细胞白血病中起着重要作用,因为这些细胞无法自身合成天冬酰胺。由于细菌来源的酶具有免疫原性和各种副作用,因此人们尝试用哺乳动物酶(如人源天冬酰胺酶 III(hASNaseIII))来替代这些酶。本研究通过分子动力学模拟、量子力学/分子力学方法和自由能计算来研究 hASNaseIII 的反应机制。我们的模拟表明,尽管酶的活性位点残基来自单个单体,但酶的二聚体形式在稳定活性位点中的底物方面起着至关重要的作用。单体-单体相互作用对于保持酶的活性构象至关重要。我们对反应机制的研究表明,自切割过程生成 N 端残基(Thr168)对于激活酶是必需的。该残基作为亲核试剂,在其羟基向 N 端氨基转移质子后,攻击底物的亲电碳原子。反应机制以形成酰-酶复合物及其水解为特征,这是决定步骤。我们提出的酶促机制阐明了不同活性位点残基的作用,并合理化了突变研究。这里提供的关于 hASNaseIII 活性的见解有助于理解不同 ASNases 之间的差异,甚至可能指导设计具有改进性质的新型变体用于急性淋巴细胞白血病治疗。